Drug & Medication
Table of Contents
Competitor Analysis: Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics The present Competitive Intelligence Report about RSV Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, small molecules and RNAi against infection with respiratory syncytial virus (RSV) as of June 2012. Purchase of the downloadable pdf report includes a 6-month online access to t...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Amrita
+1 718 303 2019
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...
PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as ...
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of ...
... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...
... vaccination 1988: before the global polio eradication initiative endemic non-endemic who. Global polio eradication initiative. Available at: http ...
Reportlinker.com © Copyright 2014. All rights reserved.